Fig. 1 · Structure

Documents & Downloads

TCRS-417

PBX1 Inhibitor

TCRS-417 is a selective PBX1 inhibitor that effectively disrupts the binding of PBX1 to DNA, exhibiting an IC50 value of 6.58 μM. This compound attenuates PBX1-mediated transcriptional activity and diminishes stemness traits in Carboplatin-resistant cancer cells, promoting differentiation through modulation of the PBX1 signaling cascade. TCRS-417 has been shown to significantly reduce the self-renewal and proliferation of cancer cells with elevated PBX1 expression and decrease mRNA levels of oncogenes such as FOXM1, NEK2, and E2F2. Moreover, TCRS-417 demonstrates selective cytotoxicity towards chr1q-amp myeloma and solid tumor cells, highlighting its potential for therapeutic use in oncology.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 2032123-28-5
Applications PBX1 Inhibitor
Formula C25H19FN2O5
Molecular Weight 446.43
Synonyms T417
SMILES
O=C(C1=CC(F)=CC=C1)NC2=CC=C(C3=C2C=CC=C3)OCC(NC4=CC=C(C(O)=C4)O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...